EU Clinical Trial 2015-001192-48

Traitement du ptosis des dystrophies musculaires oculo-pharyngées par autogreffes de myoblastes.  Mar 4, 2019

Main objective of the trial: amélioration du ptosis amélioration du ptosis

Parties

Sponsors
Keywords
Congenital hereditary muscular dystrophy Myoblastes autologues

JSON preview

Similar records

Title

Source:  EMA Last updated:  May 30, 2019

From ClinicalTrialsRegister.eu, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.